Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
ORegan, The PI3K/AKT/mTOR pathway in breast cancer: targets, trials and biomarkers
The See more button is for visual users only to expose content incrementally that is already available to you Details Condition New All content is available to screen readers from the outset
What Is the Process Like
GSDMD is required for effector CD8 + T cell responses to lung cancer cells
US$ 21.94
US$ 28.55
US$ 26.17
US$ 21.63
US$ 25.49
US$ 28.07
US$ 24.74
US$ 28.20
